Aspen Aerogels, Inc. Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Business Highlights
Rhea-AI Summary
Aspen Aerogels (NYSE: ASPN) reported strong financial results for Q4 and FY 2024. The company achieved $452.7 million in FY 2024 revenue, a 90% year-over-year increase, with gross margins growing to 40%. Q4 revenue reached $123.1 million, up 46% YoY, including record Energy Industrial revenue of $53.1 million.
The company reported net income of $13.4 million for FY 2024 (including a $27.5 million one-time charge) and Adjusted EBITDA of $89.9 million. Q4 delivered net income of $11.4 million and generated $20.9 million in free cash flow. The company ended 2024 with $220.9 million in cash.
Aspen secured a new PyroThin® Thermal Barrier contract with Volvo Truck and announced plans to halt construction of its Statesboro plant, opting instead to maximize capacity at existing facilities. For Q1 2025, the company projects revenue between $75-95 million with Adjusted EBITDA ranging from breakeven to $15 million.
Positive
- 90% YoY revenue growth to $452.7M in FY 2024
- Gross margin improvement to 40% from 24% in 2023
- Net income of $13.4M in 2024 vs loss of $45.8M in 2023
- Adjusted EBITDA of $89.9M vs -$22.9M in 2023
- New contract win with Volvo Truck
- Strong cash position of $220.9M
- $20.9M free cash flow generated in Q4
Negative
- Halting construction of Statesboro plant project
- Expected Q1 2025 net loss between $15M and breakeven
- Restructuring costs of $3.0M projected for Q1 2025
- $27.5M one-time charge from convertible note redemption
News Market Reaction 1 Alert
On the day this news was published, ASPN declined 23.40%, reflecting a significant negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
FY 2024 gross margins grew to
Record Energy Industrial revenue in Q4 of
Ended the year with
External manufacturing facility capable of increasing capacity; demobilizing
Awarded PyroThin® Thermal Barrier contract for Volvo Truck commercial vehicle program
Total revenue for the fourth quarter of 2024 was
Adjusted EBITDA for the fourth quarter of 2024 was
Total revenue for the full year 2024 was
Adjusted EBITDA for the full year 2024 was
A reconciliation of net income (loss) to Adjusted EBITDA is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."
Fourth Quarter 2024 Financial Highlights
- Record Company revenues of
, up$123.1 million 46% year-over-year (YoY)- Thermal Barrier:
of revenue, up$70.0 million 32% YoY - Energy Industrial:
of revenue, up$53.1 million 70% YoY
- Thermal Barrier:
- Supplied ~
91% of Energy Industrial revenues through external manufacturing facility, compared to ~10% in Q4 2023 - Delivered gross margins of
38% , a three-percentage point improvement YoY - Net income of
, an$11.4 million improvement YoY$11.9 million - Adjusted EBITDA of
, a$22.7 million or$13.6 million 149% improvement YoY - Operating Income of
, a$14.7 million improvement YoY$13.3 million - Cash generated from operations of
in the quarter drove$35.7 million of free cash flow$20.9 million
Fiscal Year 2024 Financial Highlights
- Total revenue of
, up$452.7 million 90% YoY- Thermal Barrier:
of revenue, up$306.8 million 179% YoY - Energy Industrial:
of revenue, up$145.9 million 13% YoY
- Thermal Barrier:
- Delivered gross margins of
40% , a sixteen-percentage point improvement over 2023 - Net income of
, which included a$13.4 million one-time charge from the redemption of the Company's convertible note, a$27.5 million improvement YoY$59.2 million - Adjusted EBITDA of
, a$89.9 million YoY improvement$112.8 million - Capital expenditures of
, an$86.3 million reduction versus 2023; CAPEX excluding$89.2 million Statesboro plant project of$42.4 million - Ended the year with cash and equivalents of
$220.9 million
New Thermal Barrier Customer Award
"Our financial results for 2024 underscore the scalability of our business model and leading market position," commented Don Young,
Thermal Barrier Supply and Statesboro Plant Project Update
To meet long-term aerogel demand,
Ricardo C. Rodriguez, Chief Financial Officer and Treasurer, noted, "In early 2023, pre-empting a reset in EV demand expectations, we decided to right-time the construction of our planned second aerogel manufacturing facility in
Q1 2025 Financial Outlook
- Q1 revenue is expected to range between
and$75 $95 million - Q1 Net loss is expected to range between
and breakeven$15.0 - Q1 Net loss per share is expected to range between
and breakeven$0.18 - Q1 Adjusted EBITDA is expected to range between breakeven and
$15 million - Q1 Capital Expenditures, excluding demobilization costs related to the
Statesboro plant project, are expected to be less than$7 million
Mr. Rodriguez added, "In 2024 we continuously beat expectations and benefited from a large initial buildup of finished vehicle inventory as we supplied several successful launches in our Thermal Barrier business. We enter 2025 excited about our Company's prospects and mindful that vehicle production will now be more directly driven by sales. To thrive in a broad range of demand outcomes and keep driving profitability, we've taken actions to right-size our fixed cost base and continue reducing our CAPEX."
The Company's Q1 2025 outlook assumes depreciation and amortization of
A reconciliation of net loss to non-GAAP Adjusted EBITDA for the 2025 financial outlook is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."
Last Twelve-Month Financial Comparison
A comparison of key financial metrics for the trailing twelve-month periods ended December 31, 2023 and 2024:
($ in millions, numbers may not total due to rounding) | |||||
Metric | FY 2023 | FY 2024 | Delta | % Improvement | |
Revenue | 239 | 453 | 214 | 90 % | |
Gross Profit % Margin | 57 24% | 183 | 126 | 221 % | |
Net Income (Loss) % Margin | (46) ( | 13 | 59 | 129 % | |
Adjusted EBITDA % Margin | (23) ( | 90 | 113 | 492 % | |
Operating Income % Margin | (49) ( | 55 | 104 | 211 % | |
Total CAPEX | 175 | 86 | (89) | 51 % | |
Conference Call and Webcast Notification
A conference call with
Shareholders and other interested parties may call +1 (404) 975-4839 (domestic) or +1 (929) 526-1599 (international) and reference conference ID "890624" to participate in the conference call. In addition, the conference call and an accompanying slide presentation will be available live as a listen-only webcast hosted at the Investors section of
Following the live event, an archived version of the webcast will be available on
Non-GAAP Financial Measures
In addition to providing financial measurements based on generally accepted accounting principles in
Management believes that this non-GAAP financial measure reflects
The non-GAAP financial measure does not replace the presentation of
About Aspen Aerogels, Inc.
Special Note Regarding Forward-Looking and Cautionary Statements
This press release and any related discussion contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to
ASPEN AEROGELS, INC. | ||||||||
Condensed Consolidated Balance Sheets | ||||||||
(Unaudited and in thousands) | ||||||||
December 31, | December 31, | |||||||
2024 | 2023 | |||||||
(In thousands) | ||||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 220,882 | $ | 139,723 | ||||
Restricted cash | 394 | 248 | ||||||
Accounts receivable, net | 109,104 | 69,995 | ||||||
Inventories | 47,551 | 39,189 | ||||||
Prepaid expenses and other current assets | 31,517 | 17,176 | ||||||
Total current assets | 409,448 | 266,331 | ||||||
Property, plant and equipment, net | 459,276 | 417,227 | ||||||
Operating lease right-of-use assets | 20,854 | 17,212 | ||||||
Other long-term assets | 5,566 | 2,278 | ||||||
Total assets | $ | 895,144 | $ | 703,048 | ||||
Liabilities and Stockholders' Equity | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 44,361 | $ | 51,094 | ||||
Accrued expenses | 36,495 | 22,811 | ||||||
Deferred revenue | 2,199 | 2,316 | ||||||
Finance obligation for sale and leaseback transactions | 4,028 | — | ||||||
Operating lease liabilities | 3,279 | 1,874 | ||||||
Long term debt - current portion | 19,750 | — | ||||||
Total current liabilities | 110,112 | 78,095 | ||||||
Revolving line of credit | 42,131 | — | ||||||
Long term debt | 94,961 | — | ||||||
Convertible note - related party | — | 114,992 | ||||||
Finance obligation for sale and leaseback transactions long-term | 10,087 | — | ||||||
Operating lease liabilities long-term | 23,148 | 21,906 | ||||||
Total liabilities | 280,439 | 214,993 | ||||||
Stockholders' equity: | ||||||||
Total stockholders' equity | 614,705 | 488,055 | ||||||
Total liabilities and stockholders' equity | $ | 895,144 | $ | 703,048 | ||||
ASPEN AEROGELS, INC. | ||||||||||||||||
Consolidated Statements of Operations | ||||||||||||||||
(Unaudited and in thousands, except share and per share data) | ||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||
(In thousands, except | ||||||||||||||||
Revenue | $ | 123,088 | $ | 84,219 | $ | 452,699 | $ | 238,718 | ||||||||
Cost of revenue | 75,955 | 54,601 | 269,802 | 181,797 | ||||||||||||
Gross profit | 47,133 | 29,618 | 182,897 | 56,921 | ||||||||||||
Operating expenses: | ||||||||||||||||
Research and development | 4,405 | 4,075 | 18,050 | 16,356 | ||||||||||||
Sales and marketing | 8,547 | 8,782 | 35,677 | 33,008 | ||||||||||||
General and administrative | 18,660 | 15,378 | 71,125 | 56,760 | ||||||||||||
Impairment of equipment under development | 808 | — | 3,510 | — | ||||||||||||
Total operating expenses | 32,420 | 28,235 | 128,362 | 106,124 | ||||||||||||
Income (loss) from operations | 14,713 | 1,383 | 54,535 | (49,203) | ||||||||||||
Other income (expense) | ||||||||||||||||
Interest expense, convertible note - related party | — | (2,904) | (7,550) | (5,328) | ||||||||||||
Interest income (expense), net | (3,526) | 1,002 | (4,409) | 6,534 | ||||||||||||
Income from Employee Retention Credits | — | — | — | 2,186 | ||||||||||||
Loss on extinguishment of debt | — | — | (27,487) | — | ||||||||||||
Total other income (expense), net | (3,526) | (1,902) | (39,446) | 3,392 | ||||||||||||
Income (loss) before income tax expense | 11,187 | (519) | 15,089 | (45,811) | ||||||||||||
Income tax expense | 175 | — | (1,714) | — | ||||||||||||
Net income (loss) | $ | 11,362 | $ | (519) | $ | 13,375 | $ | (45,811) | ||||||||
Net income (loss) per share: | ||||||||||||||||
Basic | $ | 0.14 | $ | (0.01) | $ | 0.17 | $ | (0.66) | ||||||||
Diluted | $ | 0.14 | $ | (0.01) | $ | 0.17 | $ | (0.66) | ||||||||
Weighted-average common shares outstanding: | ||||||||||||||||
Basic | 80,909,486 | 70,018,243 | 77,535,121 | 69,439,034 | ||||||||||||
Diluted | 82,998,580 | 70,018,243 | 80,306,690 | 69,439,034 | ||||||||||||
Analysis of Cash Flow
The following table summarizes our cash flows for the periods indicated.
Three Months Ended | ||||||||||||||||
March 31, 2024 | June 30, 2024 | September 30, 2024 | December 31, 2024 | |||||||||||||
(In thousands) | ||||||||||||||||
Net cash provided by (used in): | ||||||||||||||||
Operating activities | $ | (17,749) | $ | 6,843 | $ | 20,771 | $ | 35,684 | ||||||||
Investing activities | (25,863) | (24,827) | (20,821) | (14,751) | ||||||||||||
Financing activities | 5,259 | 8,141 | 22,158 | 86,460 | ||||||||||||
Net (decrease) increase in cash | (38,353) | (9,843) | 22,108 | 107,393 | ||||||||||||
Cash, cash equivalents and restricted cash at beginning of period | 139,971 | 101,618 | 91,775 | 113,883 | ||||||||||||
Cash, cash equivalents and restricted cash at end of period | $ | 101,618 | $ | 91,775 | $ | 113,883 | $ | 221,276 | ||||||||
Reconciliation of Non-GAAP Financial Measures
The following tables present a reconciliation of the non-GAAP financial measure included in this press release to the most directly comparable GAAP measure:
Reconciliation of Adjusted EBITDA to Net income (loss)
We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, which occur from time to time and which we do not believe are indicative of our core operating performance.
For the three and twelve months ended December 31, 2024 and 2023:
Three Months Ended | Year Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||
(In thousands) | ||||||||||||||||
Net income (loss) | $ | 11,362 | $ | (519) | $ | 13,375 | $ | (45,811) | ||||||||
Depreciation and amortization | 5,433 | 4,561 | 22,526 | 15,318 | ||||||||||||
Stock-based compensation | 2,548 | 3,188 | 12,855 | 10,954 | ||||||||||||
Other (income) expense | 3,526 | 1,902 | 11,959 | (3,392) | ||||||||||||
Loss on extinguishment of debt | - | - | 27,487 | - | ||||||||||||
Income tax expense | (175) | - | 1,714 | - | ||||||||||||
Adjusted EBITDA | $ | 22,694 | $ | 9,132 | $ | 89,916 | $ | (22,931) | ||||||||
For the three months ending March 31, 2025 financial outlook:
Three Months Ending | ||||||||
March 31, 2025 | ||||||||
Low | High | |||||||
(In thousands) | ||||||||
Net loss | $ | (15,000) | $ | — | ||||
Depreciation and amortization | 5,800 | 5,800 | ||||||
Stock-based compensation | 2,700 | 2,700 | ||||||
Other expense | 6,500 | 6,500 | ||||||
Adjusted EBITDA | $ | — | $ | 15,000 | ||||
View original content:https://www.prnewswire.com/news-releases/aspen-aerogels-inc-reports-fourth-quarter-and-fiscal-year-2024-financial-results-and-recent-business-highlights-302375296.html
SOURCE Aspen Aerogels, Inc.